Evidence map›Paper›PMID 16421598›Full record

ArticleGenes and immunity2006

A CXCL2 tandem repeat promoter polymorphism is associated with susceptibility to severe sepsis in the Spanish population.

C Flores, N Maca-Meyer, L Pérez-Méndez, R Sangüesa, E Espinosa, A Muriel, J Blanco, J Villar, GRECIA group, GEN-SEP group

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

C FloresResearch Institute (Research Center associated to Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain), Hospital Universitario NS de Candelaria, Tenerife, Spain.
N Maca-Meyer
L Pérez-Méndez
R Sangüesa
E Espinosa
A Muriel
J Blanco
J Villar
GRECIA group
GEN-SEP group
Centro de Investigaciones Biológicas Margarita Salas · ESHospital Universitario Nuestra Señora de Candelaria · ESHospital Universitario Río Hortega · ESSt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis describes a complex clinical syndrome resulting from a systemic inflammatory response to bacteria. Functional studies in animal models of sepsis have catalogued CXCL2 as a candidate gene for the development of the disease. We hypothesized that CXCL2 polymorphisms may confer susceptibility to sepsis and performed an association study using 178 severe sepsis patients and 357 population-based controls. We selected two polymorphisms from the promoter of the gene (-437A/G and -665(AC)n), and analyzed whether haplotypes or single loci were associated with disease susceptibility. An overall test of differentiation showed that haplotype distribution was not different between cases and controls (P=0.407). Likewise, -437A/G was not associated with disease susceptibility (heterozygote odds ratio (OR) 0.68 (0.47-1.03), and homozygote OR 0.86 (0.56-1.32); P=0.706). However, for the -665(AC)n, we found that the 24+/-1 repeat alleles were associated with susceptibility (heterozygote OR 2.82 (1.10-7.24), and homozygote OR 3.65 (1.41-9.43); P=0.0006). This association remained significant when using a multiple logistic regression analysis (OR 2.23; 95% confidence intervals (95% CI) 1.22-4.03; P=0.008) and after a genomic control adjustment (P=0.017). Although replicate studies and functional assays are needed, these results suggest that CXCL2 gene variants may contribute to the development of severe sepsis.

Indexed as

Genetics, PopulationPolymorphism, GeneticPromoter Regions, GeneticTandem Repeat SequencesAgedAllelesCase-Control StudiesChemokine CXCL2Chemokines, CXCDisease SusceptibilityFemaleGenetic MarkersGenetic VariationHaplotypesHeterozygoteHomozygoteChemokine CXCL2Chemokines, CXCCXCL2 protein, humanGenetic MarkersIntercellular Signaling Peptides and Proteins

Identifiers

PMID16421598
OpenAlexW1994333507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.